| RS549874193 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Brittle cornea syndrome 1, Ehlers-Danlos syndrome |
| RS549877950 |
AGTPBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration, childhood-onset |
| RS549883296 |
ORAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, tubular aggregate |
| RS549887751 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS549894501 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS549903844 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS549907428 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS549915384 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS549918589 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS549929887 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS549931193 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS549932754 |
RAX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 11, Cone-rod dystrophy 11 |
| RS549952317 |
SOS1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS549956055 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS549964658 |
HBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Delta-beta-thalassemia, HBD-related disorder |
| RS549977217 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Disorder of lung |
| RS549982601 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 4, Senior-Loken syndrome 4 |
| RS549983245 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS550006406 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS550008432 |
NDUFAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS550013624 |
ETV6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550024569 |
DOK7
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS550025279 |
SPEG
|
Health Risk |
Conflicting classifications of pathogenicity |
SPEG-related disorder, Myopathy |
| RS550027519 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS550031006 |
BRIP1
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS550032922 |
ELAC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS550033087 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS550037937 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS550038952 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550039968 |
HTRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular degeneration, Macular degeneration |
| RS550046293 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial septal defect 7, Cardiovascular phenotype |
| RS550047043 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS550048787 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS550057119 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS550060811 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Inborn genetic diseases |
| RS550068559 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS550073023 |
PRF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, Familial hemophagocytic lymphohistiocytosis 2 |
| RS550079487 |
KYNU
|
Health Risk |
Pathogenic/Likely pathogenic |
Vertebral, cardiac |
| RS550084361 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS550085228 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS550088634 |
CYP2U1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, CYP2U1-related disorder |
| RS550096037 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Usher syndrome type 2A |
| RS550100215 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550100640 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS550109690 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS550122375 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS550136320 |
KIF1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia 2, Hereditary spastic paraplegia |
| RS550137245 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS550137256 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Inborn genetic diseases |
| RS550141841 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550152153 |
SERPINH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 10, Osteogenesis imperfecta |
| RS550153707 |
COL11A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 53, Autosomal recessive nonsyndromic hearing loss 53 |
| RS550161377 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Intellectual disability |
| RS550180529 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS550187024 |
GPHN
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Inborn genetic diseases |
| RS550191337 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550191566 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS550195743 |
TEX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 25, Spermatogenic failure 25 |
| RS550196955 |
WARS1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities |
| RS550204540 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS550205958 |
LMNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adult-onset autosomal dominant demyelinating leukodystrophy, Adult-onset autosomal dominant demyelinating leukodystrophy |
| RS550208733 |
DSE
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS550211338 |
RRP1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS550212683 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Adams-Oliver syndrome 5 |
| RS550213627 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Occult macular dystrophy |
| RS550221570 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS550235275 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
KMT2A-related disorder, Inborn genetic diseases |
| RS550254092 |
CTNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS550254165 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
ADCY5-related disorder, ADCY5-related disorder |
| RS550262133 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS550263442 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS550282581 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS550285671 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS550285672 |
SLC4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS550286836 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 3, Dilated cardiomyopathy 1Y |
| RS550289472 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS550296441 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS550300834 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS550301037 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS550306157 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS550306731 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, Inborn genetic diseases |
| RS550311179 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, seizures |
| RS550312355 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures |
| RS550322372 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PIEZO1-related disorder |
| RS550325115 |
RAB3GAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS550333338 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550348868 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, Hyperinsulinemic hypoglycemia |
| RS550349189 |
CTNND2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS550358395 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Osteogenesis imperfecta |
| RS550362834 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS550371466 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS550384315 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS550385131 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS550385924 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS550387143 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS550400764 |
IGFN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS550402717 |
SIX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootorenal syndrome 2, Branchiootorenal syndrome 2 |
| RS550411377 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS550414401 |
EDAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Ectodermal dysplasia 10A |
| RS550415126 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolman disease, Lysosomal acid lipase deficiency |